Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M, Andarini S, Zaini J, Xin H, Kanehira M, Suzuki T, Fukuhara T, Mizuguchi H, Hayakawa T, Saijo Y, Nukiwa T, Kikuchi T.
Nukiwa M, et al. Among authors: saijo y.
Eur J Immunol. 2006 Apr;36(4):1019-27. doi: 10.1002/eji.200535549.
Eur J Immunol. 2006.
PMID: 16525992
Free article.